Management of direct antiviral agent failures

por Buti, María, Esteban, Rafael
Publicado 2016

From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis

por Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

por Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Prisons: an important link in the elimination of Hepatitis B

por Barreira-Díaz, A, Buti, M
Publicado 2021

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date

por Bersanelli, Melissa, Leonardi, Francesco, Buti, Sebastiano
Publicado 2018

The bHLH network underlying plant shade‐avoidance

por Buti, Sara, Hayes, Scott, Pierik, Ronald
Publicado 2020

Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review

por Mazzaschi, Giulia, Quaini, Federico, Buti, Sebastiano
Publicado 2022

Hedgehog Is a Positive Regulator of FGF Signalling during Embryonic Tracheal Cell Migration

por Butí, Elisenda, Mesquita, Duarte, Araújo, Sofia J.
Publicado 2014

Systemic adjuvant therapies in renal cell carcinoma

por Buti, Sebastiano, Bersanelli, Melissa, Donini, Maddalena, Ardizzoni, Andrea
Publicado 2012

Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report

por Bordi, Paola, Tiseo, Marcello, Baldari, Giorgio, Buti, Sebastiano
Publicado 2016

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

por Buti, Sebastiano, Leonetti, Alessandro, Dallatomasina, Alice, Bersanelli, Melissa
Publicado 2016

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

por Leonetti, Alessandro, Leonardi, Francesco, Bersanelli, Melissa, Buti, Sebastiano
Publicado 2017

Family history of cancer and DNA damage response genes: Two sides of the same coin?

por Cortellini, Alessio, Bersanelli, Melissa, Ficorella, Corrado, Buti, Sebastiano
Publicado 2018

Impact of the COVID-19 pandemic on HCV elimination in Spain

por Buti, Maria, Domínguez-Hernández, Raquel, Casado, Miguel Angel
Publicado 2021

Renal cell carcinoma and viral infections: A dangerous relationship?

por Bersanelli, Melissa, Casartelli, Chiara, Buti, Sebastiano, Porta, Camillo
Publicado 2022

Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials

por Bersanelli, Melissa, Petrelli, Fausto, Buti, Sebastiano, Stanganelli, Ignazio
Publicado 2021

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B

por Roade, Luisa, Riveiro-Barciela, Mar, Esteban, Rafael, Buti, Maria
Publicado 2021

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

por Facchinetti, Francesco, Bordi, Paola, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello
Publicado 2018